Recurring concern
Inadequate controls for hallucinogen-related psychosis risks
First reported 18 Dec 2020•Latest report 21 Jun 2022
What this concern includes
Includes failures of controls specifically dedicated to preventing, recognising, assessing or responding to psychosis risks associated with hallucinogenic substances, including consideration of recipients' mental-health status before dispensing, recognition of hallucinogen exposure by mental-health professionals, and related clinical guidance, training, warnings or escalation.
Not included
- Excludes generic mental-health awareness, training or treatment deficiencies where hallucinogen-related psychosis risk is not identified.
- Excludes general drug regulation, substance misuse or poisoning concerns that do not specifically involve hallucinogen-related psychosis risk.
- Excludes psychosis unrelated to hallucinogenic substances.
- Excludes generic dispensing, prescribing or medication-safety failures where the hallucinogen-related psychosis risk is not the deficient control.
- Reports
- 2
- Individual concerns
- 2
- Date range
- 2020–2022
- Stated actions
- 6
Distinct published reports
A report can raise multiple concerns
First to latest report issue date
Described in published responses
Reports over time
Reports over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
Concerns and responses across reports
Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.
-
Concerns raised1
Lack of consideration of the impact of hallucinogenic substances on mentally unwell course attendees
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.2
-
Action
Ensure continued thorough screening of all prospective students before course enrolment.
Stated by Hands of Light Academy -
Action
Educate staff about hallucinogen use and its potential dangers.
Stated by Hands of Light Academy
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.2
-
Position
Records show no student by that name attended, and no Academy courses were running on the dates mentioned.
Stated by Hands of Light Academy
-
Position
The Academy does not dispense the substance concerned to students.
Stated by Hands of Light Academy
-
Concerns raised1
Lack of Mental Health Professionals’ awareness of “Shamanic” hallucinogenic drugs and their propensity to cause or exacerbate psychosis
Responses linked to these concernsEach statement is shown once, even when linked to more than one concern.
Actions described in response An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.4
-
Action
Deliver a national suicide-reduction support programme helping local partnerships improve safety planning, substance-misuse assessment and joint working with substance-misuse services.
Stated by NHS England -
Action
Raise awareness of shamanic hallucinogenic drugs and escalate related concerns through relevant forums.
Stated by NHS England -
Action
Invest in psychological therapies for people with severe mental illness through the community mental-health transformation programme.
Stated by NHS England
-
Action
Roll out understanding-psychosis-and-bipolar-disorder training to staff working in community mental-health teams.
Stated by NHS England
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.1
-
Position
Public Health England is better placed to consider shamanic hallucinogens in its illicit drugs and medicines guidance.
Stated by NHS England
Data last updated 7 September 2026